Skip to main content

Table 1 Time schedule of enrolment, interventions, assessments, and visits for participants

From: Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

Back to article page

Trials

ISSN: 1745-6215